Compounding pharmacies perform an important role for patients who need individualized doses or formulations
It is also important for normal blood, cells, and nerves
Common Adverse Effects According to pharmaceutical research on semaglutide, gastrointestinal effects are most frequent: nausea (20-44% incidence, usually mild-moderate, improves over time), vomiting (9-24% incidence), diarrhea (20-30% incidence), constipation (20-24% incidence), and abdominal pain (8-20% incidence)
Several weight loss medications are US Food and Drug Administration (FDA) approved for weight management in adult patients with a body mass index (BMI) of 30 kg/m 2 or adults with a BMI of 27 kg/m 2 with weight-related comorbidities such as hypertension, dyslipidemia, and type 2 diabetes mellitus 1-4
Availability may vary by region, and buyers should review documentation transparency, third-party testing visibility, and regulatory requirements before purchasing